CVS Health Corp.
CVS | NYSE
$90.24
-$0.09 (-0.10%)
At close: Oct 30, 2026, 3:59 PM ET
$90.33
+$0.09 (+0.10%)
Pre-market:
Nov 2, 2026, 4:41 AM ET
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 415.09B | 407.91B | 402.07B | 394.08B | 386.64B | 378.96B | 372.81B | 368.91B | 363.25B | 360.94B | 357.78B | 347.81B | 339.2B | 330.92B | 322.47B | 315.23B | 307.86B | 299.84B | 292.11B | 285.06B | 278.32B | 271.05B |
Cost of Revenue | 356.34B | 351.32B | 346.71B | 339.39B | 333.2B | 325.72B | 321.41B | 316.53B | 309.85B | 307.32B | 303.35B | 293.44B | 285.02B | 276.48B | 268.01B | 260.93B | 254.26B | 246.9B | 240.06B | 234.71B | 228.95B | 221.52B |
Gross Profit | 58.75B | 56.59B | 55.36B | 54.69B | 53.45B | 53.24B | 51.4B | 52.38B | 53.4B | 53.62B | 54.43B | 54.37B | 54.18B | 54.44B | 54.46B | 54.3B | 53.6B | 52.94B | 52.05B | 50.35B | 49.37B | 49.52B |
Operating Income | 8.29B | 5.97B | 4.66B | 4.92B | 8.96B | 9.62B | 8.52B | 9.52B | 12.38B | 12.57B | 13.74B | 13.99B | 6.38B | 7.81B | 7.91B | 6.52B | 13.5B | 13.16B | 13.19B | 13.49B | 13.68B | 14.03B |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 5.79B | 3.46B | 2.14B | 2.91B | 6.5B | 7.19B | 6.15B | 6.73B | 9.64B | 9.87B | 11.17B | 11.58B | 4.11B | 5.67B | 5.8B | 4.26B | 10.85B | 10.45B | 10.42B | 10.08B | 9.74B | 9.96B |
Net Income | 4.91B | 2.93B | 1.77B | 469M | 4.53B | 5.28B | 4.61B | 5.02B | 7.19B | 7.32B | 8.34B | 8.6B | 2.93B | 4.06B | 4.28B | 3.28B | 8.29B | 8.04B | 7.91B | 7.58B | 7.2B | 7.4B |
Selling & General & Admin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | 50.46B | 50.62B | 50.7B | 49.78B | 44.49B | 43.62B | 42.89B | 42.86B | 41.02B | 41.05B | 40.69B | 40.38B | 47.81B | 46.62B | 46.54B | 47.77B | 40.1B | 39.78B | 38.86B | 36.87B | 35.7B | 35.49B |
Operating Expenses | 50.46B | 50.62B | 50.7B | 49.78B | 44.49B | 43.62B | 42.89B | 42.86B | 41.02B | 41.05B | 40.69B | 40.38B | 47.81B | 46.62B | 46.54B | 47.77B | 40.1B | 39.78B | 38.86B | 36.87B | 35.7B | 35.49B |
Interest Expense | 3.1B | 3.11B | 3.12B | 3.09B | 3.06B | 3.03B | 2.96B | 2.89B | 2.83B | 2.79B | 2.66B | 2.52B | 2.39B | 2.29B | 2.29B | 2.34B | 2.38B | 2.43B | 2.5B | 2.57B | 2.7B | 2.83B |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 406.8B | 401.94B | 397.41B | 389.17B | 377.69B | 369.34B | 364.29B | 359.39B | 350.87B | 348.37B | 344.03B | 333.82B | 332.83B | 323.11B | 314.55B | 308.7B | 294.36B | 286.68B | 278.92B | 271.57B | 264.65B | 257.02B |
Income Tax Expense | 916M | 568M | 408M | 2.48B | 2.01B | 1.94B | 1.56B | 1.72B | 2.44B | 2.52B | 2.81B | 2.96B | 1.16B | 1.59B | 1.5B | 965M | 2.57B | 2.42B | 2.52B | 2.49B | 2.52B | 2.55B |
Shares Outstanding (Basic) | 1.28B | 1.27B | 1.27B | 1.27B | 1.27B | 1.26B | 1.26B | 1.26B | 1.26B | 1.26B | 1.29B | 1.29B | 1.28B | 1.28B | 1.31B | 1.32B | 1.31B | 1.31B | 1.32B | 1.32B | 1.32B | 1.31B |
Shares Outstanding (Diluted) | 1.28B | 1.28B | 1.28B | 1.27B | 1.27B | 1.26B | 1.26B | 1.26B | 1.26B | 1.27B | 1.29B | 1.29B | 1.29B | 1.29B | 1.32B | 1.32B | 1.32B | 1.33B | 1.34B | 1.33B | 1.33B | 1.32B |
EPS (Basic) | 3.83 | 2.31 | 1.41 | 0.40 | 3.60 | 4.20 | 3.67 | 3.95 | 5.64 | 5.71 | 6.49 | 6.68 | 2.33 | 3.16 | 3.29 | 2.50 | 6.30 | 6.10 | 6 | 5.75 | 5.47 | 5.63 |
EPS (Diluted) | 3.78 | 2.27 | 1.38 | 0.38 | 3.58 | 4.19 | 3.66 | 3.95 | 5.63 | 5.70 | 6.47 | 6.65 | 2.31 | 3.12 | 3.24 | 2.45 | 6.24 | 6.05 | 5.96 | 5.72 | 5.45 | 5.61 |
EBITDA | 12.29B | 11.13B | 9.86B | 10.6B | 14.18B | 14.82B | 13.7B | 14.2B | 17.02B | 17.16B | 18.2B | 18.38B | 10.71B | 12.15B | 12.31B | 10.9B | 17.6B | 17.32B | 17.44B | 17.18B | 16.95B | 17.27B |
EBIT | 8.89B | 6.57B | 5.26B | 5.99B | 9.55B | 10.21B | 9.1B | 9.62B | 12.47B | 12.66B | 13.83B | 14.1B | 6.51B | 7.96B | 8.08B | 6.6B | 13.22B | 12.88B | 12.92B | 12.65B | 12.44B | 12.79B |
Depreciation & Amortization | 3.4B | 4.57B | 4.61B | 4.61B | 4.63B | 4.61B | 4.6B | 4.58B | 4.55B | 4.5B | 4.37B | 4.28B | 4.2B | 4.18B | 4.23B | 4.3B | 4.38B | 4.44B | 4.51B | 4.54B | 4.52B | 4.48B |
Add to Watchlist
Select watchlists to add or remove CVS